Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $89.46 USD
Change Today -2.46 / -2.68%
Volume 463.0K
PBYI On Other Exchanges
New York
As of 8:04 PM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Alan H. Auerbach

Founder, Chairman of The Board, Chief Executive Officer, President, Secretary and Member of Stock Option Committee,Puma Biotechnology, Inc.
AgeTotal Calculated CompensationThis person is connected to 19 board members in 2 different organizations across 5 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Alan H. Auerbach is the Founder of Puma Biotechnology, Inc., and has been its Chairman, Chief Executive Officer and President since October 4, 2011 and serves as its Secretary. Mr. Auerbach is a Private Equity Partner at Burrill Private Equity. He also serves as an Advisor at Los Angeles Syndicate of Technology, Inc. He founded Cougar Biotechnology, Inc. in May 2003 and served as its Chief Executive Officer and President since May 2003. From July 2009 to January ...

Read Full Background

Corporate Headquarters*

10880 Wilshire Boulevard
Los Angeles, California 90024

United States

Phone: 424-248-6500
Fax: 424-248-6501

Board Members Memberships*

Independent Director, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee
Founder, Chairman of The Board, Chief Executive Officer, President, Secretary and Member of Stock Option Committee


Boston University
University of Southern California

Other Affiliations*

Annual Compensation*

Total Annual Compensation$910,000

Stock Options*

All Other Compensation$11,030
Exercisable Options352,777
Exercisable Options Value$61,535,619
Unexercisable Options297,223
Unexercisable Options Value$22,836,381
Total Value of Options$84,372,000
Total Number of Options650,000

Total Compensation*

Total Annual Cash Compensation$921,030
Total Short Term Compensation$910,000
Other Long Term Compensation$11,030
Total Calculated Compensation$17,797,606
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PBYI:US $89.46 USD -2.46


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PUMA BIOTECHNOLOGY INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at